ALAlfonso Lago

Alfonso Lago

*This is an algorithmically generated author record based on publicly available information.

Alfonso Lago has a total of 101 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Effects of Scutellaria baicalensis extract on inflammatory biomarkers and performance in transition dairy cows

    by E.A. Horst, S.E. Schuling, T.L. Harris, D.E. Schimek, C.E. Moore, G. Camacho, D. Ruiz, A. Lago, F. Robert, L.K. Mamedova, et al.

    Heightened and persistent inflammation during the periparturient period impedes health and performance in early lactation. Identifying mitigation strategies capable of attenuating inflammatory cascades without interfering with the inflammation necessary to support normal physiological processes is of significant interest. Dietary supplementation of Scutellaria baicalensis extract (SBE; Dairy Relieve, Elanco Animal Health, Greenfield, IN) has been shown to improve milk performance, an effect hypothesized to be mediated by its anti-inflammatory and antioxidant properties. Thus, study objectives were to evaluate the effect of SBE supplementation on performance and inflammation in primiparous and multiparous cows and to determine the optimal feeding duration. Holstein cows (n = 404; 80 primiparous and 324 multiparous) were used in a randomized complete block design and randomly assigned within block (parity and expected calving date) to 1 of 4 dietary treatments: (1) control diet (CON), (2) 10 g/d of SBE from 255 ± 3 d carried calf (DCC) to 21 DIM (SBE42), (3) 10 g/d SBE from 255 ± 3 DCC to 90 DIM (SBE111), and (4) 10 g/d SBE from 1 to 90 DIM (SBE90). Cows were housed in a freestall barn and received the same base ration. Dietary treatments were administered individually by restraining cows in headlocks for a minimum of 10 min/d during which the top-dress pellet (113.5 g/d) containing 10 g of SBE was administered. Cows were milked 3 times daily for the first 6 wk of lactation and twice daily for the remainder of the data collection period (i.e., 40 wk). Milk yield was recorded from wk 1 to 40, and milk samples for composition analysis were obtained every 2 wk from wk 1 to 15 relative to calving. Blood samples were obtained via coccygeal venipuncture at 7, 21, and 90 DIM from a random subset of cows (24 cows/treatment). Data were analyzed using mixed effects repeated measures ANOVA. A preplanned contrast was used to estimate differences in CON versus cows supplemented with SBE to 90 DIM (SBE111 + SBE90). Over the 40-wk lactation, milk yield increased 1.5 kg/d in SBE111 relative to CON cows. Milk yield was similar in SBE42 and CON cows. Feeding SBE to 90 DIM (SBE111 and SBE90) tended to increase energy-corrected milk yield and milk fat and protein yields, whereas it tended to decrease MUN over the first 15 weeks of lactation relative to CON. Regardless of prepartum feeding, SBE supplementation to 90 DIM tended to increase circulating sirtuin-1 concentrations. Relative to CON, circulating α-1-acid glycoprotein (AGP) increased in SBE-fed cows at 7 DIM, whereas concentrations decreased at 21 DIM. In summary, the optimal feeding window of SBE for improving postpartum performance for cows enrolled in the current study was from 255 DCC to 90 DIM. Changes in circulating sirtuin-1 and AGP concentrations with SBE supplementation support the hypothesis that improved performance with SBE supplementation is partially mediated by the anti-inflammatory properties of SBE.


  • Open Access

    Invited review: Evaluation of teat disinfectant efficacy studies from 2014 to 2026. A systematic review

    by A.K. Vasquez, M. Wieland, A. Lago, S.M. Godden, V. Krömker, W. Heuwieser

    The objective was to systematically review the scientific rigor and findings of peer-reviewed studies published from January 2014 to January 2026 on the efficacy of teat disinfectants used in dairy routines. Following the methods outlined in the Cochrane Handbook for Systematic Reviews, a comprehensive search of PubMed, CAB Abstracts, and BIOSIS Previews was conducted using the terms "dairy" and "teat disinfectant" or "teat dip" within the title or Articles not written in English or that applied only in vitro methodologies were excluded. Eligible studies were screened for relevance and assessed by 2 reviewers for bias using a scoring rubric derived from evidence-based veterinary medicine checklists (e.g., CONSORT, STROBE, SYRCLE) and published guidelines. Forty-one articles met inclusion criteria, with 21 countries and 28 journals represented. Each was scored across 6 domains: identification and scope, design and execution, outcome reporting, relevance and generalizability, risk of bias and conflict of interest, and overall appraisal. Only 7 studies (17%) demonstrated high scientific merit. Of these, 6 evaluated efficacy based on udder health outcomes (e.g., new clinical or subclinical infections), and one assessed bacterial reduction on teat skin. Postmilking disinfectants were represented in 4 studies, premilking disinfectants in 2, and the last evaluated a product used for both. Germicide selection varied widely and only 2 studies evaluated similar chemicals and controls; both compared chlorine dioxide with iodine but used different application methods (brush vs. dip cup) and timings (pre- vs. postmilking). Most high-merit studies reported noninferiority between products, with odds or risk for new infections ranging from 4.0 to 7.4 per 100 quarters across treatment and control groups for each one- or 2-week period at risk. Only one showed a statistically significant advantage for the experimental product. Numerical favorability for the experimental disinfectant was reported in 4 additional high-merit studies, including one with week-dependent differences, while one study favored the control product. The bacterial reduction study showed significant decreases in log of cfu across pathogen groups, though results varied by farm and product concentration. Teat health outcomes (e.g., hyperkeratosis, skin condition) were often included but inconsistently reported. Overall, substantial variability in design and reporting quality was observed, with many studies lacking methodological rigor and applicability. Future research should prioritize guideline-based reporting, appropriate statistical methods, and transparency in funding and limitations to strengthen the evidence base for disinfectant efficacy. Given historical improvements in farm management and changes in pathogen pressures, additional consideration should be made for conducting negatively controlled, randomized clinical trials for teat disinfectants. A need remains for recent, reliable information to support consultants and farm managers in dairy practice.

  • Open Access

    Impact of a native rumen microbe supplement provided in feed on production performance and enteric methane emissions in lactating dairy cows

    by Ainhoa Valldecabres, Brooke Anderson, Josh Lefler, Clarisse Marotz, Mallory M. Embree, Alfonso Lago

    The objective of this randomized controlled study was to evaluate the effects of a native rumen microbial feed supplement on production performance (milk production, milk composition, and feed efficiency). Additionally, the effects of the microbial supplement on enteric methane emissions were assessed. Forty-six second-, third-, and fourth-parity Jersey cows at 59 ± 8 DIM were blocked by baseline milk yield and randomly assigned to control (no microbial supplementation) or treatment (GF-MFS; TMR containing 5 g/cow per day of a native rumen microbial feed supplement containing a minimum of Clostridium beijerinckii at 2 × 106 cfu/g, Pichia kudriavzevii at 2 × 107 cfu/g, Ruminococcus bovis at 2 × 107 cfu/g, and Butyrivibrio fibrisolvens at 2 × 107 cfu/g). Cows were housed in a single group and fed the study diets ad libitum for 16 wk. Individual milk yield was recorded using electronic milk meters, and milk fat and protein were measured using optical in-line analyzers at each of 2 daily milkings. Individual cow TMR intake was recorded through the Biocontrol CRFI feed intake control and measurement system. Enteric methane emissions were measured using GreenFeed units. Somatic cell count was determined in milk composite samples collected at 2 consecutive milkings on a weekly basis. Treatment and treatment by time effects were assessed by multiple linear regression. Overall treatment effects were observed for ECM, milk, and fat yields; yields were (mean ± SEM) 2.19 ± 0.90, 1.64 ± 0.74, and 0.10 ± 0.03 kg/d higher for GF-MFS compared with control cows, respectively. There was also a tendency for higher milk protein yield in GF-MFS cows. No overall treatment effects were observed for milk fat and protein concentrations and DMI. Furthermore, positive treatment effects were observed on feed efficiency (0.09 ± 0.04 units higher for GF-MFS cows) and log10 SCC (0.13 ± 0.06 units lower for GF-MFS cows). Methane intensity tended to be lower for GF-MFS compared with control cows, but methane production and yield were similar for GF-MFS and control cows. In conclusion, the supplementation of native rumen microbes effectively improved economically important outcomes such as ECM, milk and fat yields, feed efficiency, and lowered SCC. Larger studies are required to assess the effect of the evaluated native rumen microbial feed supplement on enteric methane emissions.


  • Open Access

    The effect of feeding a whey-based colostrum replacer product to calves during the first two weeks of life on calf heath and performance

    by Alfonso Lago, Claudia Leonardi, Chanda L Engel, Adam J Geiger

    Feeding transition milk to dairy calves to improve calf health is an approach that is gaining adoption on farm. However, management of transition milk can be laborious and may limit implementation. The objective of this study was to determine the effect of prolonged feeding with a whey-based colostrum replacer product (CR, Premolac, Zinpro Corporation, Eden Prairie, MN) added into the milk replacer for the first 14 d after arrival to a calf ranch on health and growth of dairy calves. A total of 1,037 newborn calves sourced daily into a calf raising facility were enrolled in the study. Calves were randomly assigned to one of three treatment groups upon arrival and fed through day 14: 1) 3.78 L/d of milk replacer not supplemented with CR (CON), 2) 3.78 L/d of milk replacer supplemented with 23 g of the CR providing 10 g.calf−1.d−1 of IgG (CR10), or 3) 3.78 L/d of milk replacer supplemented with 46 g of the CR providing 20 g.calf−1.d−1 of IgG (CR20). Treatments did not have an effect on overall grain intake (P = 0.295). However, calves fed CR20 gained more weight than calves fed CR10, and calves fed CR10 gained more than CON calves during the first 14 d of the study (P < 0.01). Average daily gain through 14 d was 0.15, 0.20, and 0.24 kg.d−1 for calves fed CON, CR10, and CR20. Supplementing milk replacer with CR20 tended to reduce (P = 0.06) the incidence of calves treated with antibiotics for diarrhea. There was no treatment effect (P = 0.11) on incidence of calves with an overall respiratory score ≥ 5 or for any of the respiratory score components (eye, nasal, ear, cough, and breathing scores). Overall, CR supplementation significantly reduced (P = 0.03) the incidence of calves treated with antibiotics for any reason. The incidence of calves treated with antibiotics was 92.4%, 88.7%, and 86.2% for CON, CR10, and CR20. Finally, mortality was significantly reduced (P < 0.01) by more than two-thirds for CR20. Mortality was 6.6, 5.4, and 2.0% for CON, CR10, and CR20. In conclusion, supplementing milk replacer with 46 g of CR (20 g IgG) for 14 d after arrival at a calf ranch was a successful strategy to significantly reduce disease incidence, antimicrobial use, and calf mortality. The addition of 46 g of CR (20 g IgG; CR20) had a greater magnitude of effect on reducing disease, antibiotic use, and mortality than 23 g of CR (10 g IgG; CR10).


  • Open Access

    Insights into cow-level risk factors for highly pathogenic avian influenza H5N1 clinical disease in lactating Holsteins from a single outbreak in Colorado: An observational study

    by A. Rico, B. Nicks, A. Lago, N. Silva-Del-Rio

    Summary: This observational study examined cow-level risk factors associated with clinical highly pathogenic avian influenza (HPAI) H5N1 in lactating Holsteins during a May 2024 outbreak on a dairy farm in Colorado. Using herd records, the study aimed to characterize clinical cases, evaluate the association between pregnancy and clinical disease, and identify risk factors specific to pregnant cows. Overall, 14.0% of the herd developed clinical disease, with incidence varying across pens (ranging from 7% to 27%), even among those housing cows with similar characteristics. Pregnant cows were 4.9 times more likely to develop clinical disease compared with nonpregnant cows, whereas cows with multiple lactations had 2.1 times greater odds compared with first-lactation cows. These results suggest that pregnancy status, parity, and pen-level factors may play an important role in determining susceptibility to clinical disease during an HPAI outbreak in dairy cattle.


  • Open Access

    Relative availability of 5 inorganic magnesium sources in nonpregnant nonlactating Holstein cows

    by N. Silva-Del-Rio, L.C. Solórzano, A. Lago, R.R. Lobo, J.P. Goff, W.P. Weiss, R.J. Tempelman

    Inorganic sources of Mg are commonly used in dairy cow diets, but their availability varies significantly. This study assessed the relative availability of 4 commonly used inorganic Mg sources and a novel alkalinizing proprietary mineral blend [PMB; Multesium (GLC Minerals, LLC, Green Bay, WI, USA)]. The study was a duplicated 6 × 6 Latin square, with 12 nonlactating, non-pregnant Holstein dairy cows assigned to a square based on BW and parity. Cows were fed 90% of their voluntary DMI (diet contained 0.21% Mg). Each experimental period lasted 7 d. On d 2 of each period, urinary catheters were fitted. Total urine collection started on d 3 for 48 h with samples collected and measured every 12 h. On d 4, 30 g of Mg were administered as boluses with gelatin capsules: negative control (one empty capsule), magnesium oxide (MgO), magnesium sulfate (MgSO4), calcium magnesium hydroxide [CaMg(OH)4], calcium magnesium carbonate [CaMg(CO3)2], and PMB [a blend of Ca and Mg sources that includes CaMg(CO3)2, CaMg(OH)4, and MgO]. Blood samples were collected at 0, 1, 2, 3, 12, and 24 h after treatment administration on d 4 of each treatment period. Urine and blood samples were analyzed for Mg and Ca concentration. Statistical analyses were conducted with PROC GLIMMIX including treatment, time, period, square, treatment × time, treatment × period, and time × period as fixed effects, and cow nested within square as a random effect in the model. Urinary Mg excretion for 4 of the Mg sources studied [PMB, MgO, CaMg(OH)4, and MgSO4] increased significantly, representing an increase of at least 40.8% relative to control. The supplementation of CaMg(CO3)2 did not significantly increase relative to control. There were no significant changes in blood Mg concentration with treatment; but, a significant treatment × time effect was observed. Calcium-rich sources [PMB, CaMg(OH)4, CaMg(CO3)2] had lower blood Mg concentrations at 12 or 24 h after treatment than control and CaMg(CO3)2. Based on urinary Mg excretion 24 h after treatment, 4 of the Mg sources evaluated (including PMB) showed a similar availability, however, the availability of the commercial CaMg(CO3)2 source included in our study was similar to the negative control (no-supplemented cows).


  • Open Access

    Selective treatment of clinical mastitis: Assessment of the net cash impact on dairy farms under diverse scenarios—A European perspective

    by A. Rico, D. Armstrong, N. Brady, L. León, A. Hancock, A. Lago

    Selective treatment of clinical mastitis (STCM) potentially reduces antimicrobial use without negative implications on cow's milk production or health. However, this approach comes with additional costs. The aim of this study was to evaluate the net cash impact (NCI) of implementing STCM compared with blanket treatment of clinical mastitis (BTCM) under different diagnostic-test turnaround times (24 h, 14 h, and 8 h) using a stochastic partial budget analysis with Monte Carlo simulation. The target population was European commercial dairy herds; therefore, the model inputs were primarily from European sources. Additionally, variables associated with dairy management programs were obtained from USDA sources, worldwide multisite clinical trials, and expert opinion. The output was calculated by subtracting the cost of STCM from the cost of BTCM and it represented the expected NCI if a herd switched from BTCM to STCM. Depending on the time-to-treatment efficiency and diagnostic-test turnaround time, the expected mean NCI, assuming that STCM has no impact on the cow's future health or production, ranged from +€8.7 to +€12.4 per case with 72.4% to 84.8% of the iterations being ≥ €0. Moreover, using the numerically favorable health and production effects of STCM reported in the literature, the expected mean NCI ranged from +€44.5 to +€48.1 per case with 93.6% to 95.4% of the iterations being ≥ €0. The variables with the greatest contribution to NCI variance were proportion of gram-positive cases (39.2% of the variance) and days out of the tank for treated cows (22.0%). However, if future cow's health and production were accounted for, culling risk (24.6%), recurrence risk (19.4%), and milk yield (10.6%) would have the greatest contribution to NCI. The sensitivity analysis indicated that farms with high clinical mastitis incidence, low proportion of gram-positive cases, large number of days out of the tank for treated cows, higher milking frequency or using automatic milking systems, not using the highest priced diagnostic tests, and having high antimicrobial treatment costs are the best candidates for STCM. Improving time-to-treatment efficiency, for example, by using a rapid diagnostic test, leads to a favorable NCI, while high daily milk yield and milk price enhances the NCI in already positive scenarios. Finally, the cash flow entirely depends on future cow's health and milk yield. In conclusion, results indicate that overall, STCM is a practice that positively impacts the NCI of many herds.


  • Top Cited Papers
    Open Access

    Invited review: Selective treatment of clinical mastitis in dairy cattle

    by Ellen de Jong, Kayley D. McCubbin, David Speksnijder, Simon Dufour, John R. Middleton, Pamela L. Ruegg, Theo J.G.M. Lam, David F. Kelton, Scott McDougall, Sandra M. Godden, et al.

    Treatment of clinical mastitis (CM) and use of antimicrobials for dry cow therapy are responsible for the majority of animal-defined daily doses of antimicrobial use (AMU) on dairy farms. However, advancements made in the last decade have enabled excluding nonsevere CM cases from antimicrobial treatment that have a high probability of cure without antimicrobials (no bacterial causes or gram-negative, excluding Klebsiella spp.) and cases with a low bacteriological cure rate (chronic cases). These advancements include availability of rapid diagnostic tests and improved udder health management practices, which reduced the incidence and infection pressure of contagious CM pathogens. This review informed an evidence-based protocol for selective CM treatment decisions based on a combination of rapid diagnostic test results, review of somatic cell count and CM records, and elucidated consequences in terms of udder health, AMU, and farm economics. Relatively fast identification of the causative agent is the most important factor in selective CM treatment protocols. Many reported studies did not indicate detrimental udder health consequences (e.g., reduced clinical or bacteriological cures, increased somatic cell count, increased culling rate, or increased recurrence of CM later in lactation) after initiating selective CM treatment protocols using on-farm testing. The magnitude of AMU reduction following a selective CM treatment protocol implementation depended on the causal pathogen distribution and protocol characteristics. Uptake of selective treatment of nonsevere CM cases differs across regions and is dependent on management systems and adoption of udder health programs. No economic losses or animal welfare issues are expected when adopting a selective versus blanket CM treatment protocol. Therefore, selective CM treatment of nonsevere cases can be a practical tool to aid AMU reduction on dairy farms.


  • Open Access

    Selective treatment of nonsevere clinical mastitis does not adversely affect cure, somatic cell count, milk yield, recurrence, or culling: A systematic review and meta-analysis

    by Ellen de Jong, Lien Creytens, Sarne De Vliegher, Kayley D. McCubbin, Mya Baptiste, Alexander A. Leung, David Speksnijder, Simon Dufour, John R. Middleton, Pamela L. Ruegg, et al.

    Treatment of clinical mastitis (CM) contributes to antimicrobial use on dairy farms. Selective treatment of CM based on bacterial diagnosis can reduce antimicrobial use, as not all cases of CM will benefit from antimicrobial treatment, e.g., mild and moderate gram-negative infections. However, impacts of selective CM treatment on udder health and culling are not fully understood. A systematic search identified 13 studies that compared selective versus blanket CM treatment protocols. Reported outcomes were synthesized with random-effects models and presented as risk ratios or mean differences. Selective CM treatment protocol was not inferior to blanket CM treatment protocol for the outcome bacteriological cure. Noninferiority margins could not be established for the outcomes clinical cure, new intramammary infection, somatic cell count, milk yield, recurrence, or culling. However, no differences were detected between selective and blanket CM treatment protocols using traditional analyses, apart from a not clinically relevant increase in interval from treatment to clinical cure (0.4 d) in the selective group and higher proportion of clinical cure at 14 d in the selective group. The latter occurred in studies co-administering nonsteroidal anti-inflammatories only in the selective group. Bias could not be ruled out in most studies due to suboptimal randomization, although this would likely only affect subjective outcomes such as clinical cure. Hence, findings were supported by a high or moderate certainty of evidence for all outcome measures except clinical cure. In conclusion, this review supported the assertion that a selective CM treatment protocol can be adopted without adversely influencing bacteriological and clinical cure, somatic cell count, milk yield, and incidence of recurrence or culling.


  • Open Access

    Effects of rumen-native microbial feed supplementation on milk yield, composition, and feed efficiency in lactating dairy cows

    by Ainhoa Valldecabres, Sean P Gilmore, Jordan J Embree, Ivan Z Zhelev, James R Gaffney, Clarisse A Marotz, Fan Yang, Andrew S Izzo, Mallory M Embree, Alfonso Lago

    The objective of this study was to evaluate the effects of two rumen-native microbial feed supplements (MFS) on milk production, milk composition, and feed efficiency. A total of 90 multiparous cows between 40 and 60 d in milk were enrolled in a randomized block design study. Within each block (baseline milk yield), cows were randomly assigned to: control (no microbial feed supplementation), MFS1 (0.33 g/kg total mixed ration [TMR] of an MFS containing a minimum of Clostridium beijerinckii at 2 × 106 CFU/g and Pichia kudriavzevii at 2 × 107 CFU/g), or MFS2 (0.33 g/kg TMR of a MFS containing a minimum of C. beijerinckii at 2 × 106 CFU/g, P. kudriavzevii at 2 × 107 CFU/g, Ruminococcus bovis at 2 × 107 CFU/g, and Butyrivibrio fibrisolvens at 2 × 107 CFU/g). Cows were housed in a single group and fed the study diets ad libitum for 270 d. Individual milk yield was recorded using electronic milk meters, and milk fat and protein were measured using optical in-line analyzers at each of two daily milkings. Treatment and treatment by time effects were assessed through multiple linear regression analyses. Treatment effects were observed for milk and energy-corrected milk (ECM) yields, milk fat and protein yields and concentrations, dry matter intake (DMI), and feed efficiency; those effects were conditional to time for milk yield, DMI, and feed efficiency. Overall, milk, ECM, fat, and protein yields were higher for MFS2 compared with control cows (+3.0, 3.7, 0.12, and 0.12 kg/d, respectively). Compared with MFS1, milk yield was higher and protein yield tended to be higher for MFS2 cows (+2.9 and 0.09 kg/d, respectively). In contrast, MFS1 cows produced 0.17 and 0.08 units of percentage per day more fat and protein than MFS2 cows, and 0.07 units of percentage per day more protein than control cows. Dry matter intake and feed efficiency were higher for MFS2 cows compared with MFS1 cows (+1.3 kg/d and 0.06, respectively), and feed efficiency was higher for MFS2 cows compared with control cows (+0.04). Where observed, treatment by time effects suggest that the effects of MFS2 were more evident as time progressed after supplementation was initiated. No effects of microbial supplementation were observed on body weight, body condition score, somatic cell count, or clinical mastitis case incidence. In conclusion, the supplementation of MFS2 effectively improved economically important outcomes such as milk yield, solids, and feed efficiency. This study evaluates the effects of two rumen-native microbial feed supplements (MFS) on milk yield, composition, and feed efficiency in lactating dairy cows. Ninety multiparous Holstein cows between 40 and 60 d in milk were assigned to control (no microbial feed supplementation), MFS1 (Clostridium beijerinckii and Pichia kudriavzevii), or MFS2 (C. beijerinckii, P. kudriavzevii, Ruminococcus bovis, and Butyrivibrio fibrisolvens) total mixed ration supplementation. Overall, MFS2 cows had higher milk and milk component yields than control and MFS1, while MFS1 cows had higher milk component concentrations than control and MFS2. Feed efficiency was higher for MFS2 compared with control and MFS1 cows. Microbial feed supplementation improved economically important outcomes such as milk yield, solids, and feed efficiency.